VEGF is key target for new anti-angiogenesis drugs, Spanish team reports

Links shared publicly online about this topic.

  • 1,188
    total visits

VEGF is key target for new anti-angiogenesis drugs, Spanish team reports

news-medical.net

Analyzing the expression of particular genes in lung cancers could soon allow researchers to identify groups of patients who are likely to benefit most from treatment with angiogenesis-inhibitor drugs, a Spanish team reports.

View full resource at news-medical.net

Tags: Cancer, Lung Cancer, Lung, Drug, Genes, News

  • Share

Most Recently Shared on May 6, 2010 at 1:14 pm By:

Lung_Cancer_ News-Medical.Net

Lung Cancer News: VEGF is key target for new anti-angiogenesis drugs, Spanish team reports: Analyzing the expressi... http://bit.ly/aJn8cO

2 years ago...

Advertisement